We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,113 hedge funds and large institutions have $48.7B invested in Thermo Fisher Scientific in 2016 Q4 according to their latest regulatory filings, with 141 funds opening new positions, 388 increasing their positions, 434 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 141 | Existing positions closed: 55

7% more funds holding

Funds holding: 1,0441,113 (+69)

1.33% less ownership

Funds ownership: 88.67%87.34% (-1.3%)

11% less repeat investments, than reductions

Existing positions increased: 388 | Existing positions reduced: 434

12% less capital invested

Capital invested by funds: $55.2B → $48.7B (-$6.44B)

35% less funds holding in top 10

Funds holding in top 10: 9360 (-33)

46% less call options, than puts

Call options by funds: $123M | Put options by funds: $228M

Holders
1,113
Holders Change
+69
Holders Change %
+6.61%
% of All Funds
27.82%
Holding in Top 10
60
Holding in Top 10 Change
-33
Holding in Top 10 Change %
-35.48%
% of All Funds
1.5%
New
141
Increased
388
Reduced
434
Closed
55
Calls
$123M
Puts
$228M
Net Calls
-$105M
Net Calls Change
-$130M
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
401
Sterling Capital Management
North Carolina
$5.89M +$3.8M +25,808 +162%
KIC
402
Keating Investment Counselors
Florida
$5.87M +$25.8K +175 +0.4%
LFM
403
Lumina Fund Management
New York
$5.86M +$6.12M +41,500 New
BA
404
Boston Advisors
Massachusetts
$5.85M -$1.3M -8,788 -17%
OPERF
405
Oregon Public Employees Retirement Fund
Oregon
$5.82M -$7.59M -51,511 -56%
NC
406
Nitorum Capital
New York
$5.73M +$5.99M +40,600 New
AAF
407
Andra AP-fonden
Sweden
$5.71M -$1.93M -13,100 -24%
MKC
408
M. Kraus & Co
Vermont
$5.7M +$119K +805 +2%
SCCM
409
Schafer Cullen Capital Management
New York
$5.66M -$22.1K -150 -0.4%
B
410
BP
United Kingdom
$5.64M -$1.33M -9,000 -18%
CIP
411
Chartwell Investment Partners
Pennsylvania
$5.64M
HHMI
412
Howard Hughes Medical Institute
Maryland
$5.64M
CANY
413
Caxton Associates (New York)
New York
$5.64M +$5.9M +40,000 New
SAM
414
Securian Asset Management
Minnesota
$5.59M +$48.2K +327 +0.8%
CT
415
Coastline Trust
Rhode Island
$5.57M +$5.16K +35 +0.1%
TAF
416
Tredje AP-fonden
Sweden
$5.56M +$270K +1,834 +5%
ProShare Advisors
417
ProShare Advisors
Maryland
$5.52M +$1.12M +7,585 +24%
IRF
418
IBM Retirement Fund
New York
$5.46M -$23.7K -161 -0.4%
BC
419
Brinker Capital
Pennsylvania
$5.43M +$5.67M +38,477 New
CCT
420
Country Club Trust
Missouri
$5.43M +$1.42M +9,627 +33%
AIM
421
Arcadia Investment Management
Michigan
$5.43M +$1.41M +9,545 +33%
EAM
422
EULAV Asset Management
Florida
$5.4M -$46.3K -314 -0.8%
WIC
423
Whitegate Investment Counselors
New Hampshire
$5.4M -$68.9K -467 -1%
MAM
424
Mastrapasqua Asset Management
Tennessee
$5.36M -$39.8K -270 -0.7%
SAM
425
Steinberg Asset Management
New York
$5.36M -$3.89M -26,360 -41%

TMO Hedge Fund Activity: Q4 2016 in Review

1,113 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2016, worth a combined $48.7B — down 12% from $55.2B a quarter earlier.

Buyers outnumbered sellers: 141 funds opened new TMO positions and 55 closed out — a net gain of 86 holders — while 388 added to existing stakes and 434 trimmed.

The largest buyer was Generation Investment Management, adding an estimated $246M. The largest seller was T. Rowe Price Associates, cutting an estimated $845M.

  • 1,113 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2016, up from 1,044 in Q3 2016.
  • Funds reported $48.7B of Thermo Fisher Scientific stock for Q4 2016, down 12% quarter-over-quarter.
  • 141 funds opened new Thermo Fisher Scientific positions in Q4 2016 and 55 closed out, a net change of +86 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2016 was Generation Investment Management, an estimated $246M added.
  • The largest Thermo Fisher Scientific seller in Q4 2016 was T. Rowe Price Associates, an estimated $845M sold.

Based on aggregated 13F filings for Q4 2016.